Experimental cell therapy tested for Tough-to-Treat lymphoma
NCT ID NCT05020015
First seen Mar 31, 2026 · Last updated Apr 21, 2026 · Updated 2 times
Summary
This study is testing an experimental cell therapy called TAK-007 in adults whose B-cell lymphoma has returned or not responded to prior treatments. The main goals are to check the safety of the treatment and see if it can shrink or eliminate the lymphoma. Participants receive chemotherapy to prepare their body, followed by one or three injections of TAK-007, and then are closely monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California, 90048, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
DUHS Duke Blood Cancer Center
Durham, North Carolina, 27705, United States
-
MedStar Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Saint Davids South Austin Medical Center
Austin, Texas, 78704, United States
-
Sylvester Comprehensive Cancer Center University of Miami Hospitals and Clinics
Miami, Florida, 33136, United States
-
Thomas Jefferson University Sidney Kimmer Cancer Center, Clinical Research Organization
Philadelphia, Pennsylvania, 19107, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.